ArticleCureus2025

Luseogliflozin Suppresses Late-Night Basal Glycemic Variability in Type 2 Diabetes: A Retrospective Observational Study.

Keishi YamauchiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.